Silvia Juliana Trujillo Cáceres

Ms. Silvia Juliana Trujillo Cáceres

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2022 in The Lancet Microbe
Verified
Journal Article
Open access
SGSergio Alejandro Gomez-Ochoa
Sergio Alejandro Gomez-Ochoa
MPMelissa Pitton
Melissa Pitton
LVLuca G Valente
Luca G Valente
CVCristian David Sosa Vesga
Cristian David Sosa Vesga
JLJorge Largo
Jorge Largo
YQYok-Ai Que
Yok-Ai Que
Antimicrobial resistance of bacterial pathogens is an increasing clinical problem and alternative approaches to antibiotic chemotherapy are needed. One of these approaches is the use of lytic bacterial viruses known as phage therapy. We aimed to assess the efficacy of phage therapy in preclinical animal models of bacterial infection. In this systematic review and meta-analysis, MEDLINE/Ovid, Embase/Ovid, CINAHL/EbscoHOST, Web of Science/Wiley, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Google Scholar were searched from inception to Sept 30, 2021. Studies assessing phage efficacy in animal models were included. Only studies that assessed the efficacy of phage therapy in treating established bacterial infections in terms of survival and bacterial abundance or density were included. Studies reporting only in-vitro or ex-vivo results and those with incomplete information were excluded. Risk-of-bias assessment was performed using the Systematic Review Centre for Laboratory Animal Experimentation tool. The main endpoints were animal survival and tissue bacterial burden, which were reported using pooled odds ratios (ORs) and mean differences with random-effects models. The I2 measure and its 95% CI were also calculated. This study is registered with PROSPERO, CRD42022311309. Of the 5084 references screened, 124 studies fulfilled the selection criteria. Risk of bias was high for 70 (56%) of the 124 included studies; therefore, only studies classified as having a low-to-moderate risk of bias were considered for quantitative data synthesis (n=32). Phage therapy was associated with significantly improved survival at 24 h in systemic infection models (OR 0·08 [95% CI 0·03 to 0·20]; I2=55% [95% CI 8 to 77]), skin infection (OR 0·08 [0·04 to 0·19]; I2 = 0% [0 to 79]), and pneumonia models (OR 0·13 [0·06 to 0·31]; I2=0% [0 to 68]) when compared with placebo. Animals with skin infections (mean difference -2·66 [95% CI -3·17 to -2·16]; I2 = 95% [90 to 96]) and those with pneumonia (mean difference -3·35 [-6·00 to -0·69]; I2 = 99% [98 to 99]) treated with phage therapy had significantly lower tissue bacterial loads at 5 ± 2 days of follow-up compared with placebo. Phage therapy significantly improved animal survival and reduced organ bacterial loads compared with placebo in preclinical animal models. However, high heterogeneity was observed in some comparisons. More evidence is needed to identify the factors influencing phage therapy performance to improve future clinical application. Swiss National Foundation and Swiss Heart Foundation.

27 August 2025 in BMC Medicine
Verified
Journal Article
Open access
PDF file
VAVicente Artola Arita
Vicente Artola Arita
MCManuel Castro Cabezas
Manuel Castro Cabezas
JVJuliana Alexandra Hernández Vargas
Juliana Alexandra Hernández Vargas
Silvia Juliana Trujillo CáceresSilvia Juliana Trujillo Cáceres
Silvia Juliana Trujillo Cáceres
NPNathalie Mendez Pernicone
Nathalie Mendez Pernicone
GCGRIPonMASH Consortium
GRIPonMASH Consortium
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of liver-related morbidity and mortality. Lifestyle interventions like the Mediterranean diet (MD) and exercise are recommended for management, but the most effective lifestyle approach remains unclear. A comprehensive literature search was conducted in Embase, MEDLINE via Ovid, Cochrane Central, and Web of Science Core Collection from inception to April 1, 2025, without language restrictions. We included randomized controlled trials (RCTs) in adults with MASLD or metabolic dysfunction-associated steatohepatitis (MASH) assessing the MD and/or exercise interventions on anthropometric measures, liver enzymes, and indices or grades of liver steatosis and fibrosis. The mean difference and corresponding 95% confidence interval (CI) were pooled using a random-effects model. Risk of bias was assessed with ROB-2, and evidence certainty was evaluated using GRADE. From a total of 4806 search results, 37 unique RCTs met the inclusion criteria, from which 11 assessed the MD and 27 exercise, either aerobic, resistance, or in combination, and two RCTs assessed the effect of the MD and exercise combination. Meta-analyses showed that the MD in comparison with the control significantly reduced body weight [weighted mean difference (WMD = − 2.38 kg, 95% CI − 4.11 to − 0.66), body mass index (WMD = − 0.70 kg/m2, 95% CI = − 1.03 to − 0.36), waist circumference (WC) (WMD = − 1.56 cm, 95% CI − 3.02 to − 0.09), and alanine aminotransferase (ALT) (WMD = − 3.96 IU/L, 95% CI − 6.54 to − 1.38). Aerobic and combined aerobic-resistance exercises in comparison with the control group reduced body weight (WMD = − 1.56 kg, 95%CI − 2.31 to − 0.82; WMD = − 1.90 kg, 95%CI − 3.59 to − 0.22, respectively). In addition, aerobic exercise significantly decreased WC (WMD = − 2.14 IU/L, 95%CI − 2.87 to − 1.41) and resistance exercise reduced ALT (WMD = − 15.40 IU/L, 95%CI − 28.60 to − 2.20) in patients with MASLD/MASH compared to the control group. The MD and aerobic exercise, whether alone or combined with resistance training, support weight loss and improve liver health in patients with MASLD/MASH. Standardized methods for measuring and reporting outcomes are essential to build robust evidence on the impact of lifestyle changes on clinical outcomes. PROSPERO registration code. CRD42024577846.

27 March 2021 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
JCJulieth Carolina Castillo-Cañón
Julieth Carolina Castillo-Cañón
Silvia Juliana Trujillo CáceresSilvia Juliana Trujillo Cáceres
Silvia Juliana Trujillo Cáceres
WBWilson Bautista-Molano
Wilson Bautista-Molano
AVAna María Valbuena-García
Ana María Valbuena-García
DFDaniel G. Fernández-Ávila
Daniel G. Fernández-Ávila
LALizbeth Acuña-Merchán
Lizbeth Acuña-Merchán

13 June 2022 in Revista Cuidarte
Verified
Journal Article
Open access
PDF file
LRLyda Z. Rojas
Lyda Z. Rojas
JVJuliana Alexandra Hernández Vargas
Juliana Alexandra Hernández Vargas
Silvia Juliana Trujillo CáceresSilvia Juliana Trujillo Cáceres
Silvia Juliana Trujillo Cáceres
SGSandra Lucrecia Romero Guevara
Sandra Lucrecia Romero Guevara
Introduction: The 2019 coronavirus disease (COVID-19) pandemic, should be an opportunity to ensure greater visibility of nursing in health systems and society worldwide. Objective: Review and synthesize the patterns on COVID-19 and nursing research, identifying the main journals, country of origin, language, topics, designs, and area of applicability of the results. Materials and Methods: Systematic review. Searches in PubMed, CINAHL, LILACS, and EMBASE databases (from the inception of the pandemic to May 15, 2020) were performed. Articles of any language related were related to SARS-CoV-2 infection or COVID-19 disease and nursing in any of its roles (care, management, education, among others) and using any epidemiological design or a scientific report were included. Two reviewers independently selected the studies and extracted the data. The main findings from the included studies were summarized through narrative synthesis and descriptive tables. The characteristics of the studies were presented as absolute values and proportions. Results: Three hundred and sixty-five articles were assessed for eligibility. Thirty-eight were included, published in 28 journals. Of those, 53.57% (n=15) were nursing specific. Most articles were “narrative reviews”, accounting for 23.68% (n=9). Most studies were conducted in China (n=18, 47.37%), followed by the United Kingdom and the United States. Thirty-four (89.47%) articles were published in English, followed by Portuguese and Chinese. We identified five areas of application of the results, and the most frequent was the “clinical” setting with 47.00% (n=18). Discussion: These findings are crucial to give visibility to nursing work during the emergency of the COVID-19 pandemic. Mental health was the main research topic, while the clinical setting concentrates the major number of articles. This pattern was aligned with the challenges of the initial phase of the pandemic. Conclusion: Future research should explore the current state of evidence in the main topics identified in this review and continue to give visibility to work carried out by nursing in the emergency of the COVID-19 pandemic. How to cite this article: Rojas LZ, Hernández Vargas JA, Trujillo-Cáceres SJ, Romero Guevara SL. Contribution of nursing research to fighting against COVID-19 pandemic. A systematic review. Revista Cuidarte. 2022;13(2):e2545. http://dx.doi.org/10.15649/cuidarte.2545 

15 May 2026 in Maturitas
Verified
Journal Article
Open access
Silvia Juliana Trujillo CáceresSilvia Juliana Trujillo Cáceres
Silvia Juliana Trujillo Cáceres
ZRZayne M. Roa-Díaz
Zayne M. Roa-Díaz
CFCatalina Paz Figueroa
Catalina Paz Figueroa
JVJuliana Alexandra Hernández Vargas
Juliana Alexandra Hernández Vargas
LRLyda Z. Rojas
Lyda Z. Rojas
OFOscar H. Franco
Oscar H. Franco
Despite numerous definitions and theoretical models, healthy living remains conceptually fragmented, lacking a unified framework capturing its dynamic, multilevel, and life-course nature. We systematically identify and conceptually analyse definitions and theoretical models of healthy living (1) to characterise heterogeneity in definitions, dimensions, antecedents, and consequences, (2) to develop a typology, and (3) to propose a unifying conceptual model. We conducted a systematic review with an embedded concept analysis. Embase, Medline, Cochrane Central, Web of Science, CINAHL, LILACS, and Google Scholar were searched from inception to May 18, 2025, without restrictions, following PRISMA 2020 guidelines. Eligible studies included conceptual analyses or theoretical models explicitly defining healthy living; empirical studies without conceptual grounding were excluded. Systematic review methods governed study identification, selection, and data extraction. Following this mapping stage, the Walker and Avant framework was applied to synthesise attributes, antecedents, and consequences, integrated with iterative thematic analysis. Of 10,067 records screened, 36 studies (1991-2025; 18 countries) were included. Definitions and theoretical justifications were highly heterogeneous. Nine conceptual dimensions and six categories of antecedents emerged, with most models emphasising physical, behavioural, and cognitive dimensions and individual-level determinants, while interactions across dimensions were rarely specified. Five major model types and ten subtypes emerged. We define healthy living as a dynamic, multidimensional life-course process integrating behavioural-physical, cognitive-psychological, social-relational, and contextual-structural dimensions. This study addresses longstanding conceptual fragmentation and proposes a four-dimensional model of healthy living, providing a foundation for theory, measurement, intervention design, and policy.

16 August 2023 in International Journal of Cardiology Cardiovascular Risk and Prevention
Verified
Journal Article
Open access
MUManuel Urina-Jassir
Manuel Urina-Jassir
APAndrés Felipe Patiño-Aldana
Andrés Felipe Patiño-Aldana
LHLina Johana Herrera-Parra
Lina Johana Herrera-Parra
JVJuliana Alexandra Hernández Vargas
Juliana Alexandra Hernández Vargas
Silvia Juliana Trujillo CáceresSilvia Juliana Trujillo Cáceres
Silvia Juliana Trujillo Cáceres
MUMiguel Alberto Urina-Triana
Miguel Alberto Urina-Triana
People living with HIV (PLWHIV) are at a higher risk of developing coronary artery disease (CAD). We aimed to assess the factors associated with CAD among PLWHIV in Colombia. We conducted a retrospective cohort study based on adults newly diagnosed with HIV, reported to the Colombian HIV/AIDS registry from 2018 to 2021. Baseline demographic and clinical characteristics were compared by age (<50 and ≥ 50 years). Our main outcome was the presence of CAD. Logistic regression models were used to assess the association between traditional and HIV-related factors with CAD. These associations were also evaluated in stratified models by age. Effect measures were odds ratios (OR) and their 95% confidence intervals. Among 36,483 PLWHIV, the frequency of CAD was 0.53% (n = 196). There was a high prevalence of impaired fasting glucose/diabetes mellitus (12.62%), overweight/obesity (27.79%), elevated LDL-c (86.69%), and hypertriglyceridemia (72.76%). Factors associated with CAD included male gender (OR: 2.01, 95% CI: 1.12–3.58), age ≥50 years (OR: 4.96, 95% CI: 3.29–7.45), lipoatrophy or lipodystrophy (OR 5.12, 95% CI: 1.12–23.33), AIDS-defining conditions (OR: 1.83, 95% CI: 1.07–3.12), obesity (OR: 2.95, 95% CI: 1.69–5.10), diabetes mellitus (OR: 2.50, 95% CI: 1.25–4.97), and renal impairment (OR: 3.15, 95% CI: 1.83–5.42). Traditional CAD risk factors are common in PLWHIV. There were traditional and disease-specific factors associated with increased odds of CAD. These findings may aid clinicians and decision-makers in reducing the impact of CAD in PLWHIV.